<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR82">
 <label>82.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fukuda</surname>
    <given-names>MM</given-names>
   </name>
   <name>
    <surname>Krudsood</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mohamed</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Green</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Warrasak</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Noedl</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Euswas</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ittiverakul</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Buathong</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Sriwichai</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>RS</given-names>
   </name>
   <name>
    <surname>Ohrt</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <article-title>A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria</article-title>
  <source>PLoS One</source>
  <year>2017</year>
  <volume>12</volume>
  <issue>11</issue>
  <fpage>e0187376</fpage>
  <?supplied-pmid 29121061?>
  <pub-id pub-id-type="pmid">29121061</pub-id>
 </element-citation>
</ref>
